Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression

BACKGROUND: There is evidence supporting the use of ketamine in treatment-resistant depression (TRD). However, there are some safety and tolerability concerns associated with ketamine. This study aimed to investigate ketamine’s safety and tolerability to the central nervous system and to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Włodarczyk, Adam, Cubała, Wiesław J., Gałuszko-Węgielnik, Maria, Szarmach, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138297/
https://www.ncbi.nlm.nih.gov/pubmed/34046159
http://dx.doi.org/10.1177/20451253211011021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138297/
https://www.ncbi.nlm.nih.gov/pubmed/34046159
http://dx.doi.org/10.1177/20451253211011021

Ejemplares similares